SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Archit Organosys informs about newspaper publication

09 Feb 2026 Evaluate
Pursuant to Regulation 30 read with Schedule III Part A Para A and Regulation 47 of SEBI Listing Regulations, Archit Organosys has enclosed copies of newspaper advertisements published for the Financial Result pertaining to quarter and nine months ended on 31st December, 2025, in Western Times (English Edition) and Western Times (Gujarati Edition) on 08th February 2026. The advertisement also includes a Quick Response code and the weblink to access complete financial results for the said period. The above information is also available on the website of the Company www.architorg.com and Website of stock exchange https://www.bseindia.com/.

The above information is a part of company’s filings submitted to BSE. 

Archit Organosys Share Price

42.10 -1.16 (-2.68%)
13-Apr-2026 16:01 View Price Chart
Peers
Company Name CMP
BASF India 3580.10
Tata Chemicals 718.85
SRF 2427.55
Pidilite Inds. 1330.00
Deepak Nitrite 1475.10
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×